Though the company has not announced which diseases it will look to treat first, it will likely rely on its massive database with the genetic information of more than 750,000 individuals. Genetic data can help pharmaceutical companies develop new drugs with fewer side effects or to modify the genes themselves to make the condition less severe. They also have not announced whether they will partner with another pharmaceutical company to start developing drugs, or whether they will go it alone.